Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Olumiant 4mg Tablet

Prescription Icon
Prescription Required

Marketer

Eli Lilly and Company India Pvt Ltd

Salt Composition

Baricitinib (4mg)

Overview Olumiant 4mg Tablet

Baricitinib 4mg tablets, a Janus kinase inhibitor, are indicated for moderate-to-severe rheumatoid arthritis. This medication alleviates joint pain, tenderness, and swelling by suppressing inflammation, thereby retarding the progression of bone and joint deterioration. Baricitinib 4mg tablets may be administered with or without food, but consistent daily timing is recommended. Dosage is individualized, contingent upon your health status and other medications. Strictly adhere to your physician's prescribed regimen; abrupt cessation should only occur under medical supervision to avoid potential exacerbation of your condition. Common adverse effects include upper respiratory tract infections, nausea, and viral infections. Other symptoms, such as oral herpes, malaise, or common cold manifestations (nasal congestion, sneezing, sore throat), may also occur. Less frequent, but potentially serious, side effects include thromboembolic events and gastrointestinal perforations, necessitating immediate medical attention. Consult your doctor about any concerns. Pre-treatment blood work is usually required. Individuals with active infections, a history of tuberculosis, herpes zoster, hepatic or renal impairment, hepatitis B or C, or venous thromboembolism should discuss their suitability for this therapy with their physician. Baricitinib 4mg may increase infection susceptibility; therefore, minimize contact with contagious individuals (e.g., those with varicella, rubeola, or influenza). This medication is contraindicated in patients under 18 years of age and during pregnancy or breastfeeding unless deemed medically necessary. Regular medical monitoring may be required.

Uses of Olumiant 4mg Tablet

Chronic inflammatory joint disease

Major Benefits of Olumiant 4mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Olumiant 4mg tablets can be consumed with or without food, though consistent timing is recommended.

Common Side effects of Olumiant 4mg Tablet:

  • Upper respiratory tract infection
  • Nausea
  • Herpes virus infection
  • Cold sores
  • Viral infection
  • Sore throat

How to use Olumiant 4mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Olumiant 4mg Tablet whole; do not crush, chew, or break it. This medication can be taken with or without food, though consistent timing is recommended.

How Olumiant 4mg Tablet works:

Baricitinib 4mg tablets, a JAK inhibitor, selectively blocks JAK1 and JAK2 enzyme activity. This action disrupts the JAK-STAT signaling cascade—a series of protein interactions crucial to immune responses, cell proliferation, apoptosis, and oncogenesis.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse reactions associated with the concurrent use of Olumiant 4mg Tablet and alcohol.

PregnancyPregnancyCONSULT YOUR DOCTOR

Baricitinib 4mg tablets should not be taken during pregnancy due to confirmed risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Baricitinib 4mg tablets pose a likely risk during lactation. Available human evidence indicates potential transfer to breast milk, potentially endangering the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Olumiant 4mg tablets.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Olumiant 4mg tablets due to potential safety concerns. Medical advice is recommended.

LiverLiverSAFE IF PRESCRIBED

For patients with liver disease, Olumiant 4mg tablets are generally considered safe, and no dosage modification is typically needed. However, in cases of severe liver impairment, its use may be inadvisable owing to insufficient data. Physician consultation is always recommended.

What if you forget to take Olumiant 4mg Tablet :

NA

Facts to Know About Olumiant 4mg Tablet

LabelValue
Chemical Type Pyrrolopyrimidine Analog
Developing Habits No.
Treatment Category Pain Relievers
Actions JAK inhibitors

FAQs on Olumiant 4mg Tablet

Tell your doctor about any liver problems before starting Olumiant 4mg Tablet. Olumiant 4mg Tablet may raise liver enzymes, so your liver function will need to be checked beforehand. While it can be used in patients with mild to moderate liver impairment, it's not suitable for those with severe impairment.
Olumiant 4mg tablets may raise the risk of certain cancers, such as lymphoma and skin cancer, by impacting the immune system. Tell your doctor about any history of cancer.
Before and during treatment with Olumiant 4mg Tablet, blood tests may be necessary to monitor for anemia, neutropenia, lymphopenia, high cholesterol, and elevated liver enzymes. These tests help ensure the medication isn't causing adverse effects. Your doctor may also recommend a tuberculosis test before starting Olumiant 4mg Tablet, as it could worsen existing infections.
Olumiant 4mg Tablet
7,085
MRP 8,200
13% off